India has recorded its first case of polio caused by a vaccine-derived poliovirus (VDPV) this year in a five-month-old child in Murshidabad district of Bengal but the country remains free of the wild poliovirus. A polio surveillance laboratory in Calcutta has found that the child from Lalbag block in Murshidabad was infected by VDPV, which occurs when the weakened virus in the oral polio vaccine (OPV) mutates over time, and regains...
More »SEARCH RESULT
Soft drink increases risk of heart attack: Study
-PTI Drinking just one can of soft drink daily may increase risk of heart attack, claims a new Harvard study but experts in India are sceptical about the findings even as they agree that excess consumption of such beverages is dangerous for health. The study, which surveyed over 40,000 men in the US for over a period of 22 years, found that taking just one sugar- sweetened drink a day increase the...
More »UN health agency unveils new data to help countries reduce deaths from tobacco use
-The United Nations Tobacco use is responsible for five million or 12 per cent of all deaths of adults above the age of 30 globally each year, according to a United Nations report unveiled today, that for the first time provides estimated mortality rates attributable to tobacco for 2004, the year before the international treaty on tobacco came into force. The Framework Convention on Tobacco Control (FCTC) that came into force in...
More »Aadhaar a potential project to improve public service: Survey
-PTI The UIDAI's Aadhaar project for providing unique identity numbers to residents, has huge potential to improve the delivery of social sector schemes like rural employment guarantee, the Economic Survey 2011-12 said. "Aadhaar has huge potential for improving operations and delivery of services," the survey said. The Unique Identification Authority of India (UIDAI), attached to the Planning Commission, is engaged in providing residents in the country a Unique Identification number (called Aadhaar) linked...
More »A historic move to make drugs affordable-G Ananthakrishnan
India's use of the compulsory licensing provision under its patents law for the first time to make the patented cancer drug Nexavar available at affordable prices is an essential, although belated step to curb the mounting cost of drugs. The grant of the licence by the Controller-General of Patents, Designs and Trade Marks to Natco Pharma for manufacture of the drug Sorafenib Tosylate (Nexavar) to treat liver and kidney cancer is...
More »